Plain-English translation of NCT05382403 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial compares a new device called the Jada® System against standard treatment for severe bleeding after childbirth. When a woman's uterus doesn't contract properly after delivering a baby and she loses too much blood despite initial medical treatment, this study tests whether the Jada® System—a device designed to help control the bleeding—works better and safer than the usual care options.
Severe bleeding after childbirth is the leading cause of maternal death worldwide, and current treatments have significant limitations. Researchers need to find safer and more effective options to help women, especially in low-income countries where this emergency is most deadly.
You likely qualify if…
You likely don't qualify if…
If you are eligible and agree to join, you will be randomly assigned to receive either the Jada® System or standard care according to the hospital's treatment protocol. If you are assigned to the Jada® System group, the device will be applied when initial medical treatment fails. If you are in the standard care group, you may receive additional medications, a blood-clotting medication, or a balloon catheter, with surgery as a backup if bleeding continues. The study will monitor your recovery and outcomes to see which approach is safer and more effective.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
Ghana
Sponsor
Women and Infants Hospital of Rhode Island
Collaborators
Washington University School of Medicine, University of Ghana
Enrollment target
~424 participants
Started
October 2023
Primary completion
August 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 44 Years
Sex
Female only
Last updated on clinicaltrials.gov in December 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Crystal Ware, BSN, CCRP
Women and Infants Hospital of Rhode Island
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.